Author

Federico Simonetta

University of GenevaORCID 0000-0002-0399-689XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Assay:bulk RNA-seq· 2 Research Focus:cancer & tumor microenvironment· 2 Research Focus:cell type annotation· 2 Research Focus:drug response / drug discovery· 2 Organism:human· 2 Research Focus:cell signaling & trafficking· 1 Assay:DNA methylation· 1

Frequent Co-Authors

Alberto J. ArribasiD· 3 shared Francesco BertoniiD· 3 shared Luciano CascioneiD· 3 shared Chiara TarantelliiD· 2 shared Davide RossiiD· 2 shared Eleonora CannasiD· 2 shared Emanuele ZuccaiD· 2 shared Filippo SprianoiD· 2 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

Alberto J. ArribasORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologyBloodPeer-reviewedMay 29, 2026

IL-16 production is a mechanism of resistance to BTK inhibitors and R-CHOP in lymphomas

Alberto J. Arribas, Eleonora Cannas, Giulio Sartori…·Francesco Bertoni

This study identifies IL-16 production as a mechanism of resistance to BTK inhibitors and R-CHOP in lymphomas, showing that targeting the IL-16/CD9 axis restores drug sensitivity.

9 citationstop 1%

humanbulk RNA-seq

𝕏 PostBluesky

ImmunologybioRxivPreprintMay 26, 2026

Ibrutinib modulates CD19 expression and improves efficacy of CD19-CAR T cells in B-cell lymphoma models

Sisi Wang, Alberto J. Arribas, Chiara Tarantelli…·Francesco Bertoni

The paper shows ibrutinib increases CD19 expression in B-cell lymphoma models, improving the effectiveness of CD19-CAR T cells.

DOI 10.64898/2026.05.22.727139

mousebulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintJan 14, 2025

A High-Throughput Bone Marrow 3D Co-Culture System to Develop Resistance to B Cell Receptor Signaling Targeted Agents in B Cell Non-Hodgkin Lymphoma

Alex Zadro, Alberto J. Arribas, Maria Vittoria Colombo…·Francesco Bertoni

This paper develops a 3D co-culture system using bone marrow stromal cells to study drug resistance in B cell non-Hodgkin lymphoma and identifies potential resistance mediators.

DOI 10.1101/2025.01.14.632958

humanorganoid / primary culture

𝕏 PostBluesky